Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | GHSR | Q92847 | 5/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16731429 | 0.85 | SLC15A2 (0.76) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL26006164 | 0.79 | SLC15A2 (0.70) | SLC15A2EPHX2SLC6A5CPB2REN | |
| SCHEMBL30175135 | 0.76 | SLC15A2 (1.00) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL22462015 | 0.76 | SLC15A2 (1.00) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL19087235 | 0.76 | SLC15A2 (1.00) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL25354642 | 0.76 | SLC15A2 (0.98) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL28851961 | 0.76 | SLC15A2 (0.98) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| SCHEMBL29813749 | 0.75 | SLC15A2 (0.61) | SLC15A2EPHX2SLC6A5CPB2REN | |
| SCHEMBL29875979 | 0.74 | SLC15A2 (0.67) | SLC15A2EPHX2SLC6A5GHSRCPB2 | |
| Acetic Acid SCHEMBL31696243 | 0.74 | SLC15A2 (0.94) | SLC15A2EPHX2SLC6A5GHSRCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9724416-B2 | Composition for improving or promoting hair growth containing, as active ingredients, photosensitizer irradiated with light and peptide, and method using same | UNIQUE MEDICARE CO., LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-20150140139-A1 | COMPOSITION FOR IMPROVING OR PROMOTING HAIR GROWTH CONTAINING, AS ACTIVE INGREDIENTS, PHOTOSENSITIZER IRRADIATED WITH LIGHT AND PEPTIDE, AND METHOD USING SAME | UNIQUE MEDICARE CO., LTD. (KR) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150140139-A1 | COMPOSITION FOR IMPROVING OR PROMOTING HAIR GROWTH CONTAINING, AS ACTIVE INGREDIENTS, PHOTOSENSITIZER IRRADIATED WITH LIGHT AND PEPTIDE, AND METHOD USING SAME | TYR, LNPEP, MET | SLC15A2 1318/4885EPHX2 969/4885SLC6A5 931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.